These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38669836)

  • 1. Effects of modafinil on nocturnal sleep patterns in patients with narcolepsy: A cohort study.
    Chin WC; Huang YS; Trevor Lam NY; Mak KY; Tang I; Wang CH; Lin C
    Sleep Med; 2024 Jul; 119():95-102. PubMed ID: 38669836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy.
    Broughton RJ; Fleming JA; George CF; Hill JD; Kryger MH; Moldofsky H; Montplaisir JY; Morehouse RL; Moscovitch A; Murphy WF
    Neurology; 1997 Aug; 49(2):444-51. PubMed ID: 9270575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J; Houghton WC
    Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group.
    Neurology; 2000 Mar; 54(5):1166-75. PubMed ID: 10720292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness.
    Schwartz JR; Nelson MT; Schwartz ER; Hughes RJ
    Clin Neuropharmacol; 2004; 27(2):74-9. PubMed ID: 15252267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy.
    Becker PM; Schwartz JR; Feldman NT; Hughes RJ
    Psychopharmacology (Berl); 2004 Jan; 171(2):133-9. PubMed ID: 14647965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.
    Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narcolepsy Severity Scale-2 and Idiopathic Hypersomnia Severity Scale to better quantify symptoms severity and consequences in Narcolepsy type 2.
    Barateau L; Chenini S; Denis C; Lorber Q; Béziat S; Jaussent I; Dauvilliers Y
    Sleep; 2024 May; 47(5):. PubMed ID: 38197577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J; Swick T; Bogan R; Lai C; Carter LP
    Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy.
    Lavault S; Dauvilliers Y; Drouot X; Leu-Semenescu S; Golmard JL; Lecendreux M; Franco P; Arnulf I
    Sleep Med; 2011 Jun; 12(6):550-6. PubMed ID: 21576035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.
    Dauvilliers Y; Bassetti C; Lammers GJ; Arnulf I; Mayer G; Rodenbeck A; Lehert P; Ding CL; Lecomte JM; Schwartz JC;
    Lancet Neurol; 2013 Nov; 12(11):1068-75. PubMed ID: 24107292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modafinil in the treatment of excessive daytime sleepiness in children.
    Ivanenko A; Tauman R; Gozal D
    Sleep Med; 2003 Nov; 4(6):579-82. PubMed ID: 14607353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of modafinil in 10 Taiwanese patients with narcolepsy: findings using the Multiple Sleep Latency Test and Epworth Sleepiness Scale.
    Yeh SB; Schenck CH
    Kaohsiung J Med Sci; 2010 Aug; 26(8):422-7. PubMed ID: 20705253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of modafinil for improving daytime wakefulness in patients treated previously with psychostimulants.
    Schwartz JR; Feldman NT; Fry JM; Harsh J
    Sleep Med; 2003 Jan; 4(1):43-9. PubMed ID: 14592359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and efficacy of armodafinil in naïve patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period.
    Schwartz JR; Khan A; McCall WV; Weintraub J; Tiller J
    J Clin Sleep Med; 2010 Oct; 6(5):450-7. PubMed ID: 20957845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of modafinil on excessive daytime sleepiness in Prader-Willi syndrome.
    De Cock VC; Diene G; Molinas C; Masson VD; Kieffer I; Mimoun E; Tiberge M; Tauber M
    Am J Med Genet A; 2011 Jul; 155A(7):1552-7. PubMed ID: 21671379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure.
    Inoue Y; Miki M; Tabata T
    Sleep Med; 2016; 27-28():45-48. PubMed ID: 27938918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life effects of modafinil for treatment of narcolepsy.
    Beusterien KM; Rogers AE; Walsleben JA; Emsellem HA; Reblando JA; Wang L; Goswami M; Steinwald B
    Sleep; 1999 Sep; 22(6):757-65. PubMed ID: 10505821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety profile of modafinil across a range of prescribing indications, including off-label use, in a primary care setting in England: results of a modified prescription-event monitoring study.
    Davies M; Wilton L; Shakir S
    Drug Saf; 2013 Apr; 36(4):237-46. PubMed ID: 23483377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.